Cervilenz Inc. to Present at IN3 East 2011

June 17, 2011 - PRLog -- Cervilenz Inc. has been selected to present at IN3 East 2011, an annual strategic partnering and investing meeting for the med-tech industry. Dean Koch, President and CEO of Cervilenz Inc., will be presenting the company's background, progress and future plans on Wednesday, June 22nd at 10:30 am at the Hyatt Regency in Boston.

Cervilenz Inc. manufactures and markets CerviLenz® – an innovative, disposable medical device that measures cervical length to help identify and manage pregnant women at high risk for preterm birth. Preterm birth is a significant public health problem that affects 12% of deliveries and is the leading cause of infant morbidity and mortality. Every year in the U.S., over 540,000 infants are born preterm with an annual economic toll of $26.2 billion dollars.

“As we continue taking steps toward full commercialization, we are receiving positive feedback from healthcare professionals and payers that confirms the market potential for CerviLenz,” Mr. Koch said. “Advances in progesterone therapy promise the first and only prevention for preterm birth. Experts are now calling for routine cervical length measurements to find the women who should be treated. CerviLenz is ready to support this new clinical need for cervical length measurements in all pregnancies to help reduce the incidence and cost of prematurity.”

CerviLenz is an immediate, reliable method for measuring the cervix in any healthcare setting, yielding actionable results that can influence treatment. CerviLenz is a significant enhancement to available technology.


About Cervilenz Inc.

Cervilenz Inc. manufactures and markets CerviLenzﾮ ﾖ an innovative, disposable medical device that measures cervical length to help identify and manage pregnant women at high risk for preterm birth. Dedicated to making a difference in the world of prematurity, Cervilenz Inc. donates a portion of revenue to charitable organizations that advance maternal and fetal health globally. Founded in 2008, the company headquarters is in Chagrin Falls, a suburb of Cleveland, Ohio. CerviLenz was designed and is manufactured in Ohio.

About IN3 East

IN3 ("investment in innovation") conferences have served for 11 years as the pre-eminent med-tech global forum for VCs, top investors, and corporate acquirers with early-/mid-/late-stage medical technology start-ups and revolutionary innovators. This is the ideal setting for strategic partnering given exclusive informal networking opportunities along with key note speakers, panel discussions, and presentations by start-ups and investors.